Slow-SPEED: Slowing Parkinson’s Early Through Exercise Dosage

by palligoelme@gmail.com | May 28, 2025 | Clinical Trials

​ Conditions: Parkinson Disease; Prodromal Stage; Neurodegenerative Diseases; Basal Ganglia Diseases; Central Nervous System Diseases; Synucleinopathies; Nervous System Diseases; Cerebral Disorder; Brain Diseases; Parkinsonian Disorders; Genetic Predisposition...

EMDR 2.0 Group Therapy for PTSD, Depression, and Anxiety in Earthquake Survivors

by palligoelme@gmail.com | May 27, 2025 | Clinical Trials

​ Conditions: Post-Traumatic Stress Disorder (PTSD); Depression; Anxiety; Disaster-Related Psychological Distress Interventions: Behavioral: EMDR 2.0 Group Protocol Sponsors: Okan University Completed Conditions: Post-Traumatic Stress Disorder (PTSD); Depression;...

Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain

by palligoelme@gmail.com | May 27, 2025 | Clinical Trials

​ Conditions: Orthopedic Disorder; Nontraumatic Injury; Upper Extremity Pain; Risky Substance Use Interventions: Behavioral: Web-TIRELESS; Other: Web-MEUC Sponsors: Jafar Bakhshaie; National Center for Complementary and Integrative Health (NCCIH) Not yet...

CLINICAL TRIAL FOR THE COMPARATIVE EVALUATION OF ACID SUPPRESSION AND SYMPTOM MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE WITH THE ADMINISTRATION OF TEGOPRAZAN OR PANTOPRAZOLE

by palligoelme@gmail.com | May 27, 2025 | Clinical Trials

​ Conditions: Gastroesophageal Reflux Disease Interventions: Drug: Tegoprazan; Drug: Pantoprazole Sponsors: Carnot Laboratories Recruiting Conditions: Gastroesophageal Reflux Disease Interventions: Drug: Tegoprazan; Drug: Pantoprazole Sponsors: Carnot Laboratories...

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

by palligoelme@gmail.com | May 27, 2025 | Clinical Trials

​ Conditions: Heart Failure Interventions: Drug: Placebo; Drug: Low Dose PF-07328948; Drug: Medium Dose PF-07328948; Drug: High Dose PF-07328948 Sponsors: Pfizer Not yet recruiting Conditions: Heart Failure Interventions: Drug: Placebo; Drug: Low Dose PF-07328948;...